51 phd-position-in-computer-vision Postdoctoral research jobs at Nature Careers in Germany
Sort by
Refine Your Search
-
research on the topic outlined above is paramount Candidates are expected to be interested in working at the boundaries of several research domains PhD degree in computational biology, bioinformatics
-
environment in the fields of science, technology and administration as well as for the education of highly qualified young scientists. The computational imaging group at DESY is concerned with the development
-
) program - one of the four scientific pillars of the upcoming FAIR (Facility for Antiproton and Ion Research) facility currently entering its commissioning phase. In particular, the DESPEC experiment
-
on the design and testing of antimicrobial compounds in response to infection-specific signals. The group is seeking to fill the position of a Postdoctoral Researcher (m/f/div) in Antimicrobial Peptide
-
preclinical in vitro and in vivo models Supervise and mentor MSc/MD/PhD students Collaborate with national and international research partners Present your results at scientific meetings Publish your findings
-
interpretation of OMICs datasets (DNA, RNA, proteome) Supervision and technical guidance of Bachelor’s, Master’s, and PhD students, as well as technical staff within the project context Participation in teaching
-
. With the advent of inertial confinement fusion (ICF) research in Germany, DESY will boost its activities in this thriving research field. We are seeking two motivated (one position can be filled with a
-
of heart disease Your studies will take advantage of in vitro and in vivo pre-clinical models, including hiPSC-derived systems The postdoctoral project will combine experimental (wet-lab) and computational
-
Post-doctoral researcher (m/f/d)in ‘‘Marine Microbial Natural Product Chemistry’’ The position is available for 3 years starting at the earliest date possible. Job Description Innovative cultivation and
-
age-related macular degeneration (AMD). AMD is the most common cause of vision loss in elderly affecting about 300 million people by 2040. Currently, there is no effective treatment for the majority